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On the basis of experiments performed more than 40 years ago, Langley (1) 
proposed a mechanism for the stimulating action of nicotine on muscle and for 
the antagonism of curare. He postulated that "receptive substances" are pres- 
ent in the neural region of the muscle, that the combination of these "radicles" 
with nicotine provides an adequate stimulus for contraction, and that curare 
competes with nicotine for the receptive substances. This concept was further 
developed quantitatively by A. J.  Clark and his coworkers (2,  3), who used 
acetylcholine (Ach) as a  stimulating agent and  studied  the inhibiting actions 
of atropine and of curare. Unfortunately this work seems to have been over- 
looked by electrophysiologists concerned with the mode of action of the "cu- 
rares." 
It is possible to apply to this problem one of the simplest of the mathematical 
formulations in common use in the field of enzyme chemistry. The theory as- 
sumes that the first step in an enzyme-medlated reaction is the formation of a 
complex between enzyme and substrate. On this basis a  relationship between 
reaction velocity and  substrate  concentration was  derived by Michaelis and 
Menten (4). Several other authors have extended the theory (5,  6). However, 
the type of equation used is applicable in certain situations which are believed 
to involve the formation of a  complex between a  small molecule and a  large 
one, usually protein, but which may involve no reaction beyond this stage. For 
example, the oxygenation of myoglobin is such a  function of the partial pres- 
sure of oxygen (7). 
The  following  experiments  offer  quantitative  support  for  the  hypothesis 
that Ach stimulates striated muscle by some process involving the formation 
at the myoneural junction of an intermediary complex of the enzyme-substrate 
type. 
Methods 
The rectus abdominis muscle of the frog was dissected out and suspended for meas- 
urement of isotonic  contraction. The muscle was  washed  in frog Ringer's solution 
buffered with sodium phosphate (10  -3 ~) and sodium bicarbonate (8.6 ×  10  -3 ~r) and 
* The investigation was  aided by a  grant from the Research  Committee of the 
Graduate School from funds supplied by the Wisconsin Alumni Research Foundation. 
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so adjusted that the pH was 1  uaintained at 7.0 when a mixture of 95 per cent oxygen- 
5 per cent carbon dioxide was bubbled through the bath. The experiments were car- 
ried out at room temperature (usually about 23°C.).  The volume of the bath was 
6.0 cc. 
The  muscle was  exposed to  tetraethyl pyrophosphate  (TEPP) 1  for 30  minutes 
(40 gg./cc.)  to destroy the cholinesterase. It was then washed for  15  minutes and 
tested with Ach until the contractions were reproducible.  2 
For stimulation of the muscle Ach bromide was added from a  solution containing 
1 ~g. (as free base) per cc. A  1 minute contraction was recorded. Since the readings 
represented rates rather than equilibrium positions the muscle was allowed to begin 
contracting before the reading was begun. The solution was changed after the meas- 
urement and the muscle allowed to rest between readings. It was found that a 5 min- 
ute rest period sufficed for contractions less than 50 per cent of the maximal. As the 
response was increased the period between readings had  to be increased to insure 
complete relaxation. When the rest periods were too short the responses near maximal 
were less than  predicted by theory, with  the  result  that  the  dose-response curve 
(Fig. 1) broke sharply and flattened out near the top. 
The character of some of these experiments is such that the muscles were inter- 
mittently active for long periods of time.  The  condition was  checked  by making 
control readings and  it has been possible to reproduce results over a  period of  12 
hours. 
The  contractions were measured by means of a  simple optical system. A  small 
concave spherical mirror (radius of curvature 1 meter) mounted on the isotonic lever 
focused the reflected image of a light source on a scale placed at a distance of 2 meters 
from the mirror. The use of this apparatus has afforded a  degree of reproducibility 
not usually obtained with a kymograph. Details of the equipment will be described 
elsewhere. 
Three  "curares"  were used in these experiments. Dihydro-fl-erythroidine hydro- 
bromide  8 was used in much of the work for the reason that it is available in crystalline 
form. The results obtained with this drug have been duplicated using intocostrin, a 
partially purified but chemically heterogeneous mixture of alkaloids, and metubine, 
the dimethyl ether--dilodide of d-tubocurarine. 
The inhibitor was incubated with the muscle for 30 minutes prior to addition of the 
Ach. Where a  series of readings was taken at a  single inhibitor concentration (Figs. 
1 Made available through the courtesy of the Central Research Department of the 
Monsanto Chemical Company, Dayton, Ohio. 
Some reversal of the cholinesterase inhibition produced by TEPP  has been re- 
ported (8) when the muscle is washed after a short period in the inhibitor. This results 
in a decreased response to ACh, which is especially evident when the response is highly 
magnified. The inhibition can be maintained by keeping a  small quantity of TEPP 
in the solution throughout the experiment. This was not done in the experiments re- 
ported here, and some error may have resulted, although in most cases magnification 
was low and such an error was probably negligible. 
8 Kindly supplied by the Medical Division of Merck and Company, Inc., Rahway, 
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2, 3, and 5) the inhibitor was present throughout the sequence; i.¢., during and be- 
tween the successive measurements. 
Theory 
The equation which describes the rate of an enzyme reaction as a  function 
of the substrate concentration is that of a rectangular hyperbola (4). An analo- 
gous equation has been used to express the rate of contraction of a muscle as a 
function of the concentration of Ach applied to it (9). As originally proposed, 
this equation did not take account of the fact that a correction must be applied 
in order that the equation describe the experimental situation. For the purpose 
of emphasizing the underlying assumptions the equation will be derived here 
and the need for the correction demonstrated. Relationships which are corol- 
laries of the fundamental assumptions will not be derived although they will 
be used throughout the paper. Their development, however, has appeared in 
several reviews (10-12). 
It is assumed that there occurs the formation of a  complex (ES) between a 
receptor or enzyme (E) and its substrate (S). The complex formation may be 
followed by a  reaction, or, as in the case of oxymyoglobin, there may be no 
subsequent reaction. Thus 
(E) +  (S) ~  (ES) ~  .....  (A) 
where the dots indicate that further steps may occur. According to the law of 
mass action, 
(E)(s) 
K,  =  .--  (1)  (~) 
where K, may be treated as the dissociation constant of the complex (ES) and 
is known as the Michaelis constant. The total receptor concentration (Et) may 
be written 
(E,) =  (E) -t- (ES)  (2) 
and, substituting for (E) in (1), 
~,  (s,)  -  (Es)  F(p.,)  ] 
=  (~s)  • (s)  =  L~  -  1  (s)  (3) 
As long as the formation of (ES) is not the rate-limiting step, the velocity of a 
subsequent reaction will be proportional to the amount of (ES)  formed; i.e., 
c =  k(ES). The maximal velocity  C,~ will be approached as Et is saturated with 
S; hence Cm =  k(E,). Then 
(.~,)  c. 
(p.s)- 
and, substituting in (3) and solving for c, 
C.(S) 
c=  (4) 
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Inspection of equation (4)indicates that c should be a hyperbolic function of 
(S), which prediction is realized for the systems cited. As (S) increases indefi- 
nitely, K, becomes negligible and c approaches C= as a  limit. That is, as the 
receptors are saturated by a very large substrate  concentration the velocity 
of the dependent reaction approaches a maximum. 
This simple situation may be altered by including  an  inhibitor. Inhibitors 
are usually divided into several classes depending on their modes of action, and 
the quantitative relationships make possible an analysis of the type. 
An inhibitor may combine with the same receptor as does the substrate, or 
it may combine at a different site on the large molecule E. In the latter case 
combination with the complex F_~ is also possible. Thus two reactions are to 
be considered: 
£  +  I~  EI  (B) 
ES +  I ~  ESI  (c) 
The kinetics are described by the equation 
C.(S)  c =  (S)  [ 
K, L I  +  +  (s) 
where I  is the concentration of inhibitor, K~ is the dissociation constant of the 
complex El, and Ke,~ is the corresponding constant of the complex ESI. 
Several limiting  cases  of this  equation  are  of practical importance.  Thus 
when no inhibitor is present (/is zero) the equation reduces to (4). When the 
inhibitor combines only with E  (reaction  (C)  does not occur), Ke,~ becomes 
infinite, and (I)/K,,~ is zero; hence equation (5) reduces to 
c~(s) 
c=  (6) 
(*) 1  + 
This is a  case of competitive inhibition, so-called because the two molecules, 
substrate and  inhibitor, are competing for the  free receptors. Occupation of 
the site by one excludes the other. 
When the inhibitor acts by combining with groups other than those which 
react with substrate, and the rate of combination is unchanged whether the 
latter are free or combined with substrate, then K~ =  K~,~. If the rate of com- 
bination is modified in the presence of S, K~ ~  K,,~ and equation (5) must be 
used as written. In either case the inhibition is not competitive. 
These equations hoM for a system in which the response begins at very small 
substrate concentrations; i.e.,  the  curve extrapolates to the origin. As is well 
known, the dose-response curve for many biological systems shows a  definite 
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apparent on inspection of Fig. 1. The origin, in this case, is below the abscissa, 
factor KCm__  (So)  where (S0) is the quantity of Ach referred to  displaced by a  as 
+  (s0) 
the threshold concentration. Denoting this "factor" by the letter a, equation 
(4) becomes 
C.(S) 
c  +a  =  .--  (7) 
K, +  (S) 
The same correction applies to equations (5) and (6). 
The equations contain three theoretical constants which are of considerable 
importance in characterizing the system. The best method for evaluation of 
IOC  c 
,  Ach Molority  x  I0 
0  ~,,,/  I  2  3 
rig  ,/ 
FIO.  1. Ach dose-response curve and effects of dihydro-fl-erythroidine.  Ordinate 
represents  rate of contraction  c (height of contraction  in 1 minute, on an arbitrary 
scale). The dotted segments are the extrapolations used in evaluating the constant a. 
--O-- no inhibitor; --X-- dihydro-/~-erythroidine 0.7 X  10  -8 M; --O-- 1.9 X 10  -s 
M; --I)--  4.7  X  10  -s M. 
these constants was developed by Lineweaver and Burke (13). If the reciprocal 
of equation (7) is taken, 
1  K,  1  1 
c+a  C.  (S) +c.  (8) 
1 
This is the equation of a  straight line obtained when c~  is plotted  against 
__  K, 
1  The intercept is ~  and the slope is equal to ~  so that, by evaluation of  (s)" 
the slope and intercept, a simple calculation gives the value of K,. 
Taking the reciprocal of equation (6), and including the correction a, 
1  K,  l-St  j,  1  1 
+  (9) 
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Equation (9)  shows that if the data are gathered at progressively increasing 
concentrations of inhibitor (competitive in this case)  a family of straight lines 
results. At zero inhibitor (9) reduces to (8). As the inhibitor concentration is 
increased the slope of the line obtained increases, but all the lines must extrapo- 
1  late to the same intercept, ~.  The common intercept gives, as will be seen, a 
unique criterion for determining whether or not a given inhibitor is competitive. 
If the reciprocal plot is made from data described by equation (5), the family 
of lines obtained allows some insight into possible mechanisms of inhibition. In 
this case 
c  +  a  =  c.  "  (-~ +  ~  +  x,~j  (i0) 
Some of the alternative  types of non-competitive inhibition  were discussed 
above. However, the following  points  should be stressed  here.  Equation (I0) 
also describes a family of straight lines. In the absence of inhibitor it reduces to 
(8).  If the combination is unaffected by the presence of substrate  the slope 
E  (Z) ]  for  the  but here  should increase by the factor  1 +  K~.] (as  competitive case), 
the intercept increases at the same rate. Thus, while with a  competitive in- 
hibitor the lines obtained at various concentrations have a common intercept, 
with a non-competitive inhibitor the intercepts increase as (I) increases. Where 
the combination of inhibitor with (E)  is affected by the presence of (S)  and 
Ki #  K~,~, interpretation is more difficult. Graphically this will be shown by 
different rates of change of slope and intercept--the rates depending on the 
magnitudes of the constants Ki and K,~. 
If in the case of the frog rectus an inhibitor does not act at the end-plate, but 
rather at some other point (such as the contractile mechanism), Ki becomes 
infinite and the slope of the curve is unaffected by the preser~ce of inhibitor. 
Any increase in slope therefore indicates inhibition at the end-plate, even when 
the results are complicated by other effects. 
EXPERIMENTAL 
(U) Co'repetitive  Inhibitors.--Certain  of the crystalline  "curares" were tested 
over a fairly wide concentration range and were found to exhibit an action con- 
sistent with the theory. The usual dose-response curve is plotted in Fig. 1. The 
value c is the reading (on an arbitrary scale) which represents the rate of short- 
ening of the muscle (i.e.  the height of contraction in a  given short interval of 
time). The necessity for inclusion of the correction factor, a, can be seen. This 
value has been determined graphically by extrapolation. It should be noted 
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exact.  The  data  for  several  concentrations  of  dihydro-O-erythroidine are 
plotted as reciprocals in Fig. 2. The fines have a common intercept, as required 
by equation (9). The same proof of competition has been obtained with d-tubo- 
curarine, intocostrin, and metubine. 
The constant K, can be evaluated from the slope (K°/Cm) of the fine in the 
absence of inhibitor, since Cm is known from the intercept (1/C~). With these 
data (Ko and C,), K+ can be calculated from the slope K°[1-t- ~)l/C,, of one 
of the lines obtained in the presence of the inhibitor. 
The values of the constants obtained with two of the "curates" are given in 
Table I. Since these constants are a measure of the affinity of the receptor for 
 x,o  2  oJ 
I  J 
3  ~2°  4.  ,6  ~  19  , 
/  /'/  ~x-" 
~  ~o~ 
I  x I0  "6 
S 
I  I  I  I  I 
0  I  2  3  4  5 
FIG. 2.  Data from Fig.  1 plotted as reciprocals. Symbols as in Fig. 1. The inset 
shows the entire curve in the absence of inhibitor. 
an inhibitor, the values obtained may be used to represent the "potency" of 
the drug. 
(b) Non-Competitive Inkibitors.--As has been pointed out, non-competitive 
inhibitors may fall into several classes depending on the relative magnitudes of 
K+ and K,+. The action of atropine on the myoneural junction is possibly non- 
competitive. It was noticed a number of years ago that the quantitative data 
on atropine inhibition differ from those gathered after curarization. The data 
were made more consistent with theory by assuming that each receptor com- 
bined with 1.5 molecules of the drug, but that the basic mechanism was com- 
petition (14). 
A  further study shows, however, that the effect of atropine is not one of 
simple competitive inhibition. The reciprocal plot (Fig. 3) shows that both the 
slope and the intercept increase as the inhibitor concentration increases.  In 828  ACTION  OF  IN'HIBITORS  AT  MYONEU'RAL JUNCTION 
I  I  ~,  ~  x  I0 ~' 
±  x to  "s  $ 
!  I 
o  i  , 
Fro. 3. Redpmcal plot showLng the effects of atmpL~e. --O--  without  atropine; 
--O--  atropL~e 1.5  X  10  -~ ~; --X--  3.O  X  10  -~ ~; --~D-- 4.0  X  ~0  '~ ~. 
TABLE  I 
Dissociation Constants for the Re~eptor-Substrate and Receptor-Inhlb4tor Complexes 
Experiment  Inhibitor  Ks  K~ 
Dihydro-fl-erythroidine  I 
2 
3* 
4 
5 
6 
7"~ 
8* 
9 
10 
11 
12 
13 
Atropine 
Eserine 
3.4 X  10  --7 ~s 
3.8 X  I0  -ru 
3.5 X  10--  7u 
3.0 X  10--  T  ts 
8.9 X  10-7M 
9.6 X  10-  ~ M 
3.0 X  10-7u 
2.5 X  10~M 
2.9 X  10-  ~ 
2.2 X  10-  ~ M 
2.2 X  10-7 x~ 
3.2 X  10  -7 xf 
3.3 X  10  -~s 
3.2X  10  -~u 
3.2 X  10-  su 
1.3 X  10  -~ 
1.4 X  10-  s 
1.1  X  10-4~ 
1.5 X  10  -4 ~s 
1.1  X  10-  4~s 
1.0  X  10-  4 xt 
1.6 X  10  -4 u 
1.1  X  10-  4~s 
1.5  X  10-  4 
1.3  X  10  -4 ~r 
2.0 X  10  -~ u 
* The curves from which these values were calculated appear in this paper. 
:~ Thls experiment was run in the presence of eserine, which is itself a competitive inhibitor. 
The K. calculated from the data in this figure was 4.0 X  10  -7 x~. This was corrected by divid- 
I-  "1 
/  (1)1  where (I)is the concentration of eserine used and K, is  the  average of  ing by ~1  +  K~ _]' 
the above values for eserine. 
this  case  the  intercept  increases  more  slowly  than  does  the  slope,  indicating 
that K~ <  K~,. The value for K~, included in Table I, indicates that the affanity 
of the receptors for atropine is of  the order of a  thousand times less than  the 
affinity for dihydro-O-erythroidine. L.  B.  KIRSCIINER  AND  W.  ]~.  STONE  829 
No value has been assigned to Ko,~, for the following reason: The complex 
nature of the system makes possible a number of alternative mechanisms for 
inhibition. One of these, which has been demonstrated for inhibition of nerve 
conduction by eserine, involves the penetration of the inhibitor into the fiber 
(15). The drug action, in that case, takes place not at a synapse (none was pres- 
ent in the stretch of nerve used) but within the fiber itself. It is possible that 
atropine is penetrating into the muscle fiber and exerting some action there. 
This would  diminish  the  response of the muscle to Ach. The analysis used, 
however, would give a finite value for K**i, implying that a locus on ES is re- 
acting with atropine. 
Thus, while some inhibition at the myoneural junction is evident, the data 
permit no conclusion as to whether this action is non-competitive or competitive 
since the results may be complicated by additional effects on other parts of 
the system. 
(c) Multiple Inhibitors.--It has been claimed (16) that since certain inhibitors 
deviate from the above classification there must be a fallacy in the theory. An 
attempt was made to develop another equation to fit the data. However, the 
equation used was not very satisfactory even on the introduction of an arbitrary 
power. In dealing with the system used in this type of work it is requisite to 
bear in mind its complexities. The events purported to occur at the end-plate 
are measured in terms of the contractile response of the entire muscle. This 
response is the result of a sequence of activities involving at least four unique, 
but  connected  systems:  end-plate,  conductile,  contractile  (i.e.  actomyosin), 
and energetic. Interference (by an inhibitor) in any one of the first three will 
result in  an  immediate variation in  the  response of the  muscle.  It  was  for 
such a  reason that no value was assigned  for K**~-atropine,  since the site of 
the inhibition could not be assigned to the end-plate alone with any certainty. 
Even at the end-plate the known events are mediated by two separate func- 
tional entities: the receptors which form the initial complex, and cholinesterase 
which presumably breaks down Ach after it has subserved its function. It is 
possible that a  compound which affects one of these also has  some activity 
toward  the  other,  and  indeed,  the  following experiment will  illustrate  this 
point. 
The activity of eserine is very generally described in terms of its capacity 
as a cholinesterase inhibitor. It has, however, been demonstrated that eserine 
may either potentiate or depress the postganglionic response to preganglionic 
stimulation,  depending  on  the  concentration  used  (17).  The  same  double 
activity  can  be  demonstrated  on  the  in  situ  muscle  described  above.  The 
muscle in this experiment was not pretreated with TEPP and the cholinesterase 
at the end-plates was active. In Fig. 4 the muscle was stimulated by a constant 
quantity of Ach  (eserine alone having no effect). The response was measured 
at different concentrations of eserine salicylate and plotted as a function of this 
variable. The sharp increase in response at low concentrations of eserine is well 830  ACTION  OF  INI~BITORS  AT  MYONEURAL  J~YNCTION 
known, as is the further increase on prolonging the time of exposure to eserine 
before stimulating  (greater slope in curve B  than in A). This potentiation of 
the response to Ach is the result of the inactivation of cholinesterase  (18). 
c  B,//Ox''~  ®~® 
20t~  I  Eserine  Molorlty x 104 
0  I  2  5 
Fro. 4.  Effects of esel~_ne  on response of frog rectus to 0.4 ~g. Aeh. Ordinates repre- 
sent rates of contraction in arbitrary units. -- O--  incubated for 11 minutes in eserine 
before adding Ach; --X--  incubated 25  minutes.  No TEPP was t~sed in this  ex- 
periment. 
3 c'~'~  x 1°2  "  -x/  .o" 
.//_j-  o 
, ¢;¢/  , ¢;¢/ 
~.x 10  -6 
Fro.  5.  Reciprocal plot  showing  the  curare-like action  of eserine  on  a  TEPP- 
treated muscle. --O-- no eserine; --×--  eserine 0.5 X  10  -4 M; --O-- 1.0  ×  10  -4 M. 
The striking fact, however, is that on further increasing the concentration 
of eserine  the  response  of the  muscle  to  Ach  decreases  and  (not  shown)  is 
nearly abolished  at 0.7--1.0  X  10  -8 M.  The  inhibition  was  completely  re- 
versible on washing the muscle (of. reference 8). Fig. 5 defines the mechanism 
of the inhibition.  Here the cholinesterase was inactivated by TEPP prior to 
exposure to eserine.  In this case eserine had only an inhibitory effect and it 
can be seen that the inhibition is purely competitive. L. B.  KI~SCH~V.R AND W. ~.  SXONE  :  831 
The  inference may be  drawn,  then,  that  a  single  compound may act at 
more  than one locus in  the Ach mechanism,  and  that  the  actions may be 
partially compensatory in terms of the measured response. 
In the case of the controversy cited (16,  19) the inhibitor ttaxedil (triiodide 
of  tri(fl-trimethylammonium  methoxy)-l,2,3-benzene)  did  not  follow  the 
usual competitive relationship, but became relatively less potent as its con- 
centration increased.  It is possible  that the compound was combining with 
two members of the Ach system. It may thus be analogous to eserine in exerting 
a  dual effect, though acting as a  curare at lower concentrations and as an 
anticholinesterase as  the  concentration was  raised.  Thus,  if ttaxedil has  an 
anticholinesterase activity the muscle would become more  sensitive  to  Ach 
as the concentration of flaxedil was raised and the curarization would be less 
than  predicted.  These  experiments  should be  repeated  after  cholinesterase 
has been eliminated by preincubation with TEPP. 
DISCUSSION 
The experiments reported here demonstrate the mode of action of the "cu- 
rates." They also give an indication of the difference between the action of a 
true "curare" and such a drug as atropine. Unfortunately, the action of atropine 
is too complex to be explained completely by the type of analysis used in this 
study. 
Earlier treatment of the type of data presented here led to results which were 
extremely variable. As a  result, no confidence was manifested in the values 
calculated for Ks and K¢  (2).  The variability may have been  the result of 
several factors having nothing to do with the muscle per se. Use  of  the ky- 
mograph led to some variability in early experiments. The work reported here 
was undertaken with an optical recording device and the precision of measure- 
ment has been considerably improved. Another improvement is the use of the 
Lineweaver-Burke (reciprocal plot) analysis. A possible source of error in the 
older literature  is  the  use  of partially purified, but  non-crystalline natural 
curares, the constancy of whose composition is highly questionable. 
It has been  noticed that while the  constants calculated are generally re- 
producible, a  value is occasionally encountered which is outside the normal 
range (Table I). These deviations have been noted several times in the course 
of a  great many experiments and are possibly of some physiological signifi- 
cance, although no explanation can be given at this time. Incomplete inactiva- 
tion of cholinesterase would give such a  result, but this appears unlikely at 
the cholinesterase inhibitor concentrations used. 
It is imperative in the calculation of K~ to have a precise value for K,. The 
value of K~ gives a  measure of potency which has a  theoretical significance, 
and such values could be used for comparing the potencies of new inhibitors. 
Using, say, d-tubocurarine as a  standard curare, a  series of compounds could 
be assayed on a  single muscle and the values calculated for K~ used for corn- 832  ACTION" OF  INIIIBITORS AT  MYONELrRAL  JUNCTION 
parison with the reference and with each other. If this technique is used to- 
gether with an in  ~ivo  method, such as the head drop,  information may be 
gained both on the activity of the drug on muscle directly and on how the 
animal body deals with it  (in terms of destruction etc.). 
However, the physiological implications of the results obtained in this work 
are of more importance than the pharmacological applications.  Combination 
of the results reported here with previously published  studies on  the effect 
of "curates" (20),  Ach (21),  and anticholinesterases (22) on the electrophysi- 
ology of muscle makes possible the synthesis of a coherent, if still incomplete 
picture of some of the events occurring at the neuromuscular junction. 
Close arterial injection of Ach results in the repetitive firing of the fibers of 
the muscle, and the repetitive response of a  single fiber has been recorded by 
means of a microelectrode buried in the muscle mass (21). Similar experiments 
have been reported on the synapses in a  sympathetic ganglion. Perfusion of 
the ganglion with Ach solutions results in the repetitive discharge of the post- 
ganglionic elements  (23,  24).  The magnitude of the response  increases with 
increasing Ach concentration. 
More  direct  evidence on events at  the  end-plate has been  reported  in  a 
beautiful series of experiments (25, 26). A single fiber was dissected out of the 
muscle (or a  small group of fibers used) and placed in contact with recording 
electrodes. The direct application of Ach to  the end-plate set off a  train of 
propagated electrical responses, while application of much higher concentra- 
tions of Ach to any other site had no effect. It has been shown that the initial 
event in the electrical response of the muscle to a  nervous impulse is the for- 
mation of a  local "end-plate potential," and that the latter has to attain a 
critical magnitude before the propagation of the spike occurs. Data have also 
been presented (20) to show that the direct effect of curare is to diminish the 
size of the end-plate potential. These data were not discussed at length, but 
the  curve  obtained  by  plotting  the  magnitude  of  the  end-plate  potential 
against  the concentration of curare is of the form described by Equation 6 
(assuming S,  the transmitter, to be proportional to the stimulus, which was 
held constant). 
It  should be pointed out that the real variable dependent on Ach is probably 
the end-plate potential. Apparently the frequency at which a  fiber fires is a 
function of the magnitude of this quantity. It is evidently an empirical fact 
that the rate of shortening in the frog rectus is a linear function of the average 
frequency at which the fibers are firing; hence the dose-response relationships 
can be studied by the contraction of the entire muscle. 
With respect to the data presented here for eserine it might be mentioned 
that the time course for eserinization (i.e.  the sensitizing phase) agrees with 
recently published data (27) on the time for development of a  maximal end- 
plate potential in the presence of prostigmine. L.  B.  KIRSCHNER  AND  W.  E.  STONE  833 
Up to this point a  fairly coherent picture of the initial events at the myo- 
neural junction may be constructed. There are, however, a number of experi- 
mental findings which find no place in the scheme. Magnesium paralysis and 
the roles of potassium, calcium, and adrenalin are still obscure. It is also perti- 
nent that other junctions respond in a more complex fashion than do those of 
the rectus. Much of the electrical work cited above was done on the sartorius 
of the frog and, as was pointed out, seems to confirm the predictions which 
might be made from the present experiments on the rectus. Yet the response 
of the sartorius to immersion in Ach differs from that of the rectus in that it is 
not  maintained; i.e.,  the  former relaxes after a  short  tetanus  although  the 
drug is still present in the bath. The rectus maintains the tetanus as long as 
the Ach is present. It should be stressed that the contraction of the rectus is 
a true tetanic response and not a contracture (as it is often called). The electri- 
cal response to Ach is a series of spikes the frequency of which varies with the 
concentration of Ach applied (28). The propagated electrical response of the 
sartorius, on the other hand, is cut short soon after immersion in the solution 
(27), being in this respect analogous to the contractile response. Other junc- 
tions present responses differing in some degree from the simple response of 
the rectus to the drug. However, tlae pattern of responses to Ach; curare, and 
the anticholinesterases is so similar in the variety of peripheral synapses that 
there is little doubt that the same basic mechanism operates in all of them. 
The over-all response may then be modified by superimposition of secondary 
mechanisms subserving some specific function in one tissue and not in another 
(e.g. phasic rather than tonic contraction). 
Two suggestions might be made in the interest of clarity in the literature. 
First,  the  term  "curare" should be reserved for  those  junctional  inhibitors 
whose action is competitive, and not applied to every compound which de- 
creases  a  postjunctional  response  regardless  of  locus  and  mode  of  action. 
Second, the response of the rectus to Ach is a  contraction, tetanic in nature, 
and not a  contracture as defined by Gasser  (29). The data revelant to this 
point will be submitted as part of a separate communication. 
SUMMARY 
1.  A study is presented of the actions of certain inhibitors on the frog rectus 
abdominis muscle stimulated by acetylcholine. 
2.  A type of analysis has been developed which provides a reliable criterion 
for judging whether an inhibitor is competing with acetylcholine for receptors 
at the myoneural junction or whether acting by a different mechanism. 
3.  The "curares" are shown to act by competitive inhibition at the myo- 
neural junction,  confirming earlier work of others on the mode of action of 
curare. 
4.  Atropine acts as an inhibitor at the myoneura| junction. The inhibition 834  ACTION  OF  INHIBrroRs  AT  MYONEURAL  JUNCTION 
may  be  non-competitive  or  it  may  be  complicated  by  an  additional  effect 
at some point other than the myoneural junction. 
5.  A possible mechanism  for anomalous inhibitor  effects is the action of a 
single compound at more than one locus in the Ach mechanism. Eserine exerts 
such a dual effect at the end-plate. 
6.  Some of the available electrical and  chemical data have been correlated 
to make possible a partial explanation of the role of Ach in transmission at the 
myoneural junction. 
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